Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease
| Image |  |
|---|---|
| Description | scientific article published on 01 June 2019 |
| Author/s |
author: Séverine Vermeire Karen van Hoeve Erwin Dreesen Ilse Hoffman Marc Ferrante |
| Publication date | June 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |